Extendicare Inc (EXETF) 6.7400 $EXETF Extendicare

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Extendicare Inc (EXETF) 6.7400 $EXETF

Extendicare Announces Solid 2016 Second Quarter Results
Marketwire Canada - Thu Aug 11, 4:00PM CDT
MARKHAM, ON--(Marketwired - August 11, 2016) - Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today reported results for the three and six months ended June 30, 2016. Results are presented in Canadian dollars unless otherwise noted.
EXE.TO: 8.66 (+0.04)

Extendicare Announces Voting Results From the 2016 Annual and Special Meeting of Shareholders
Marketwired - Fri May 27, 6:05PM CDT
MARKHAM, ON--(Marketwired - May 27, 2016) - Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announced the results of matters voted on at its annual and special shareholders' meeting held on May 26, 2016 (the "Meeting", which included the election as directors of the Company, all of the nominees listed in its management information and proxy circular dated April 8, 2016 (the "Information Circular". The voting results for each of the matters presented at the Meeting are presented below.
EXE.TO: 8.66 (+0.04)

Extendicare Announces 2016 First Quarter Results
Marketwire Canada - Thu May 12, 4:00PM CDT
MARKHAM, ON--(Marketwired - May 12, 2016) - Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today reported results for the first quarter ended March 31, 2016. Results are presented in Canadian dollars unless otherwise noted.
EXE.TO: 8.66 (+0.04)

Extendicare Announces Expansion of Home Health Care Business Into Vancouver Coastal Health Authority
Marketwired - Fri Apr 29, 5:27PM CDT
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) is pleased to announce the continued growth of its home health care business with an expansion into the Vancouver Coastal Health Authority.
EXE.TO: 8.66 (+0.04)

Extendicare Announces April 2016 Dividend of C$0.04 per Share
Marketwired - Fri Apr 15, 7:00AM CDT
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share" for the month of April 2016, which is payable on May 16, 2016 to shareholders of record at the close of business on April 29, 2016. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
EXE.TO: 8.66 (+0.04)

Extendicare Announces Timing of 2016 First Quarter Results and Conference Call
Marketwired - Mon Apr 04, 5:30AM CDT
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announced it will release its financial results for the first quarter of 2016 on Thursday, May 12, 2016, and will host a conference call and live audio webcast on Friday, May 13, 2016, at 10:00 a.m. (EDT) to discuss the results.
EXE.TO: 8.66 (+0.04)

Extendicare Announces Timing of 2015 Year End Results and Conference Call
Marketwire Canada - Mon Jan 25, 7:00AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announced it will release its financial results for the fourth quarter and year ended December 31, 2015, on Thursday, February 25, 2016, and will host a conference call and live audio webcast on Friday, February 26, 2016, at 9:00 a.m. (ET) to discuss the results.
EXE.TO: 8.66 (+0.04)

Extendicare Reaches Agreement With Oxford Park Group and Announces Changes to its Board of Directors
Marketwired - Fri Jan 22, 6:00AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announces that it has reached an agreement with Oxford Park Group ("Oxford Park" that is in the best interests of all of Extendicare's shareholders and other stakeholders, which enables the Company to avoid what could have been an expensive and distracting proxy contest. Pursuant to the terms of the agreement, among other items:
EXE.TO: 8.66 (+0.04)

Extendicare Announces January 2016 Dividend of C$0.04 per Share
Marketwired - Fri Jan 15, 7:00AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share" for the month of January 2016, which is payable on February 16, 2016 to shareholders of record at the close of business on January 29, 2016. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
EXE.TO: 8.66 (+0.04)

Extendicare Announces Changes to Its Board of Directors
Marketwired - Wed Jan 06, 7:02AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announces several changes to its Board of Directors, resulting from the board renewal process commenced in August 2015 following completion of the sale of the Company's U.S. operations. The objective of the process was to review the Board's composition to ensure that it continues to have the ideal mix of skills, experience and perspectives to oversee management's implementation of Extendicare's strategic plan.
EXE.TO: 8.66 (+0.04)

Extendicare Normal Course Issuer Bid Approved by TSX
Marketwired - Wed Dec 30, 7:00AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announced that it has received the approval of the Toronto Stock Exchange (the "TSX" to renew its normal course issuer bid (the "Bid" for up to 8,610,000 of its common shares (the "Common Shares" through the facilities of the TSX, and on alternative Canadian trading systems.
EXE.TO: 8.66 (+0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 342

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 44

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 13

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading